HTL-STREFA, Inc.’s Post

May, a Month of Heart Health Awareness! 🫀 At Float Group, we are deeply committed to promoting #cardiovascular health and raising awareness throughout this dedicated month. Collaborating with our partners in the #pharmaceutical industry, we are resolute in developing projects and campaigns that empower individuals to take control of their #heart health. From life-changing tools supporting HCPs and Patients, preventive #screenings, to clinical case platforms, virtual experiences, and educational initiatives sharing inspiring stories, our mission is to impact the fight against heart disease significantly. 🩺Additionally, we want to highlight the vital contributions made by patient associations and societies in encouraging a greater focus on cardiovascular health. The truth is that cardiovascular prevention should be a year-round effort, and attention to heart health is necessary every day. Connect with health for a better life.  Float.pt  #Float #FloatHealth #FloatGroup #HeartMonth #HeartHealth #HeartDisease #Cholesterol #StrokePrevention #Hypertension #Health #PatientCare #PharmaIndustry #MedTechCom #DiseaseAwareness #HealthTech #PatientEducation #InnovationInMedicine

Did you hear? The world’s first once weekly #insulin will be available across the country soon! 💉🇨🇦 🔎Do you prescribe or dispense basal insulins? Stay ahead of the learning curve and sign up for our newest mini-series on MedEssist Hub! The landscape of #diabetes management is evolving quickly, and we're here to provide you with all the essential information about long-acting insulins. This includes the newly approved once weekly basal insulin, a groundbreaking advancement in diabetes care! 🚀 📚Brought to you in collaboration with @LMC Pharmacy and CDE pharmacists Brian Lam and Natalie Shing, part 1 in this 3-part mini-series focuses on the foundational knowledge of basal insulins to help you prepare for individuals starting or switching to once weekly insulin. Some of the learning points include:  💡The different basal insulins available on the market now 💡The pros and cons of each therapy 💡When basal insulin should be started 💡And more!! With our flexible and interactive online learning, there's no reason to delay! ⏳ It’s time to take control of your professional development and enhance patient care. 🏥 Enroll now to secure your spot! Check out the course in the comments below👇

"Honored to have participated in the 5th Annual Innovation in Pharmacy Conference, focusing on 'Effective Management of Type 1 Diabetes Mellitus: A Pharmacist's Perspective on Improving Patient Outcomes.' A big thank you to the organizers and collaborators for such an insightful session! Excited to apply these learnings to better serve patients in the healthcare system. #PharmacyInnovation #Type1Diabetes #PatientCare #ContinuousLearning"

Learn more about this crucial study that highlights the significance of involving patient advisory boards to enhance medication adherence among African American individuals with Type 2 diabetes. Discover the innovative peer-led strategies that are making a difference. Read more: https://lnkd.in/dRv74HDU Authors: Maurer, M. A. et al. #Pharmacy #Type2Diabetes #AfricanAmericanHealth #PatientEngagement #MedicationAdherence 

It is critical that the criteria guidelines for discharge and follow-up are followed to the letter for the Pathway protocol to be considered successful and for the patient to go home with a management plan. Read more 👉 https://lnkd.in/e2TGYes7 #hyperglycaemia #emergencydoctor #expertwitness

“IVIG saved my quality of life; it has given me a reason to keep trying.” — Dave, living with Chronic Inflammatory Demyelinating Polyneuropathy PPTA is excited to shine a light on patients around the globe who rely on plasma-derived medicines to live healthy lives. On the first day of #IPAW2024, we are taking a deeper look into these patients' conditions and the importance of continuous availability and access to the medications that work best for them. Read more in our latest blog: https://bit.ly/3zNxhcJ

This is a topic near and dear to my heart. I lost a dear friend to hypoglycemia and I talk about him whenever I teach about the topic. Thank you Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES for working on this with me. This paper is an in depth look at the consequences associated with hypoglycemia and the use of stable glucagon but also importantly novel approaches for making sure we get glucagon in the hands of all persons at risk. Are you prescribing glucagon for ALL your patients that receive insulin? Why not? Community pharmacists are in a unique position to be able to make sure all patients who are prescribed insulin receive a prescription for glucagon. We should be empowering them just as we did with Narcan to provide this life-saving drug to our patients. I’d like to call on all prescribers to support empowering pharmacists to do just that. In the meantime, if one of them calls you and suggest prescribing insulin to one of your patients receiving insulin, please authorize that prescription. The full paper is available at this link https://lnkd.in/grmp56_X Massachusetts College of Pharmacy and Health Sciences School of Pharmacy-Boston, Massachusetts College of Pharmacy and Health Sciences

Highlighting glucagon and its role in hypoglycemia management - vital knowledge for improving patient safety

It was an honor to coauthor this paper with Jennifer D Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP. Read her important note below about the importance of prescribing this life saving medication glucagon for all people taking insulin or at risk of hypoglycemia.

Delve into the world of Medtronic Diabetes with our symposium and parallel session with a focus on unlocking the full potential of the MiniMed 780G system: Navigating complex scenarios and orphan indications in diabetes care. All the details are here: attd.kenes.com #attd2024